These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16733446)

  • 1. [Voriconazole photosensitivity: 7 cases].
    Auffret N; Janssen F; Chevalier P; Guillemain R; Amrein C; Le Beller C
    Ann Dermatol Venereol; 2006 Apr; 133(4):330-2. PubMed ID: 16733446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole-induced photosensitivity.
    Malani AN; Aronoff DM
    Clin Med Res; 2008 Sep; 6(2):83-5. PubMed ID: 18801950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole-induced retinoid-like photosensitivity in children.
    Rubenstein M; Levy ML; Metry D
    Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.
    Miller DD; Cowen EW; Nguyen JC; McCalmont TH; Fox LP
    Arch Dermatol; 2010 Mar; 146(3):300-4. PubMed ID: 20083676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole : a review of its use in the management of invasive fungal infections.
    Scott LJ; Simpson D
    Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoporphyria associated with voriconazole.
    Kwong WT; Hsu S
    J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe phototoxicity associated with long-term voriconazole treatment.
    Vöhringer S; Schrum J; Ott H; Höger PH
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):274-6. PubMed ID: 21050383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.
    Haylett AK; Felton S; Denning DW; Rhodes LE
    Br J Dermatol; 2013 Jan; 168(1):179-85. PubMed ID: 22860570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoporphyria as a result of voriconazole use: a case report.
    Dolan CK; Hall MA; Blazes DL; Norwood CW
    Int J Dermatol; 2004 Oct; 43(10):768-71. PubMed ID: 15485539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
    McCarthy KL; Playford EG; Looke DF; Whitby M
    Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl.
    Racette AJ; Roenigk HH; Hansen R; Mendelson D; Park A
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S81-5. PubMed ID: 15858516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
    Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole: a new triazole antifungal agent.
    Johnson LB; Kauffman CA
    Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/ photoaging reaction.
    Frisch S; Askari SK; Beaty SR; Burkemper CN
    J Drugs Dermatol; 2010 May; 9(5):562-4. PubMed ID: 20480802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
    Frick MA; Soler-Palacín P; Martín Nalda A; Guarner ME; Nadal CF
    Pediatr Infect Dis J; 2010 May; 29(5):480-1. PubMed ID: 20431387
    [No Abstract]   [Full Text] [Related]  

  • 17. Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Cheng MP; Paquette K; Lands LC; Ovetchkine P; Théoret Y; Quach C
    Pediatr Pulmonol; 2010 Jul; 45(7):661-6. PubMed ID: 20575095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototoxic dermatoses in pediatric BMT patients receiving voriconazole.
    Goyal RK; Gehris RP; Howrie D; Cogley KM; Windreich RM; Venkataramanan R
    Pediatr Blood Cancer; 2014 Jul; 61(7):1325-8. PubMed ID: 24619922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
    Al-Badriyeh D; Heng SC; Neoh CF; Slavin M; Stewart K; Kong DC
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):623-36. PubMed ID: 21155694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyria cutanea tarda revealed by voriconazole].
    Hickman G; Duval A; Picard C; Petit A
    Ann Dermatol Venereol; 2010 Jan; 137(1):36-9. PubMed ID: 20110066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.